Basics IDEAYA Biosciences, Inc. IPO Date: May 20, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.38B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 2.94% Avg Daily Range (30 D): $0.46 | 1.89% Avg Daily Range (90 D): $0.49 | 2.25% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): .9M Avg Daily Volume (90 D): .9M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 2,390 Avg Inst. Trade: $2.37M Avg Inst. Trade (30 D): $1.91M Avg Inst. Trade (90 D): $2.24M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.04M Avg Closing Trade (30 D): $3.54M Avg Closing Trade (90 D): $3.64M Avg Closing Volume: 117.56K     News Aug 5, 2025 @ 8:23 PM IDEAYA (IDYA) Q2 Net Loss Improves 27% Source: Jesterai Jul 22, 2025 @ 5:00 PM Melanoma Market Anticipates a Dynamic Shift During... Source: Delveinsight Jul 10, 2024 @ 12:01 PM Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.... Source: Avi Kapoor Jul 9, 2024 @ 12:31 PM Company News for July 9, 2024 - July 9, 2024 - Zac... Source: N/A Jul 8, 2024 @ 8:17 PM BTIG lifts Ideaya Biosciences target to $62 on stu... Source: Lina Guerrero Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.85 $-.88 $-.82 Diluted EPS $-3.85 $-.88 $-.82 Revenue $ 7M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -331.8M $ -77.49M $ -72.18M Operating Income / Loss $ -384.23M $ -88.81M $ -84.39M Cost of Revenue $ $ $ Net Cash Flow $ -68.51M $ -15.35M $ 45.62M PE Ratio